epic

Logo

September 6, 2024

Oscar Worried About Sunset of Exchange Premium Subsidy Enhancement Insurtech Oscar Health is worried about the potential sunset of the enhanced premium subsidies in the Exchanges. Exchange enrollment has reached 21.3 million with the enhanced subsidies, the loss of Medicaid eligibility through the reintroduction of redeterminations, and general pro-coverage policies of the Biden administration. Oscar could lose 15% to 20% of its enrollment. Oscar is focused on Exchange enrollment. The nation’s uninsured rate has increased already due to Medicaid coverage losses. The increase in the number of uninsured could worsen with the sunset of the enhanced premium subsidies. The Urban Institute found that the enhanced subsidies will lead to 7.2 million more people receiving subsidized Marketplace coverage and 4.0 million fewer people being uninsured in 2025. It also found that the 7.2 million in added enrollment also will reduce insurer premium rates by 5 percent on average. The sunset of

Read More »
Logo

September 5, 2024

Cigna Focuses On Its Services Entity’s Growth Cigna CEO David Cordani has sent a strong message that Cigna’s focus is on Evernorth, its services entity.  Cordani says its pharmacy benefits manager (PBM), Express Scripts, and specialty pharmacy are strong focuses moving forward. They are both housed in Evernorth. The attention makes sense.  Evernorth has grown tremendously and has been a huge contributor to margin.  The attention to drug costs, including creative ways to address the growth of weight-loss drugs and transitioning to biosimilars, is important.  At the same time, Cigna will see continued political pressure on the market size of its PBM. PBM reform legislation is becoming more and more likley this year. Cigna seems to think the rise of transparency will not disrupt Express Scripts placement in the market right now. Additional article: https://www.beckerspayer.com/payer/cigna-ceo-expect-choppiness-in-glp-1-coverage.html (Some articles may require a subscription.) #cigna #pbms #drugpricing #biosimilars #weightlossdrugs https://www.modernhealthcare.com/insurance/cigna-evernorth-health-services-specialty-pharmacy-pbm-david-cordani-morgan-stanley Centene Continues To Have

Read More »
Logo

September 4, 2024

Bad News on 2025 Medicare Advantage Begins To Roll Out Humana has reaffirmed its full-year guidance but gave details on the retrenchment it is doing in Medicare Advantage (MA) for 2025.  As expected, Humana announced the paring back of benefits, higher premiums, and the exit from geographies. Humana is leaving 13 markets next year because they are not profitable or poorly profitable.  In other areas, Humana is staying in but eliminating certain plans with high medical expense, which will diminish choices. Humana says about 560,000 members, or 10% of its individual MA enrollment, would be impacted by the cutbacks. About half of those will stay in Humana in other plans. That is about what Humana said it would lose earlier this year – a couple hundred thousand members. Other big plans are cutting back, too.  Centene is leaving certain markets, cutting benefits, and raising premiums. Even Humana, who is bullish

Read More »
Logo

September 3, 2024

BEA Finds Drug Price Increase Differences With And Without Rebates Factored In An interesting study from the Bureau of Economic Analysis (BEA), which set out to study whether annual drug price increases are different when factoring in rebates between drug makers and pharmacy benefits managers (PBMs) or health plans. The BEA compared claims data with rebate estimates from 2007 to 2020. It found something very interesting. Retail pharmacy prices increased by 9.1% each year. Negotiated prices, which include rebates, grew a more modest 4.3% per year. The issue here is that rebates do not regularly make it in full or sometimes even in part from the pockets of PBMs to either employer groups or to patients at the point of sale. Pointing to this is the fact that in 2016, patient out-of-pocket spending rose while negotiated cost growth largely remained flat. The increase in out-of-pocket costs is likely attributable to

Read More »
Logo

August 30, 2024

Big Pharma Now Giving More To Dems Than GOP Despite the passage of the Medicare drug price negotiations, Big Pharma companies are now giving more to Democrats than to Republicans. In the past, Big Pharma gave three or four times more to GOP candidates than to Democrats. But so far in the 2024 election cycle, drug companies have given $4.89 million to Democrats and $4.35 million to Republicans. Harris has gotten $518,571 compared with Trump at $204,748. Part of the change could be Trump’s animosity toward the drug industry as well. #drugpricing #ira #branddrugmakers https://www.medpagetoday.com/washington-watch/electioncoverage/111734 Iranian-Backed Cyber Criminals Active Several federal government agencies are warning that Iranian-backed cyber criminals have conducted a number of attacks against healthcare organizations. (Article may require a subscription.) #cyberattacks #healthcare https://www.modernhealthcare.com/digital-health/iranian-hackers-attacks-healthcare-fbi Beleaguered Walgreens Facing Shareholder Lawsuits Walgreens and its top executives are being sued by shareholders over the company’s dire financial status. The lawsuit alleges

Read More »
Logo

August 29, 2024

CMS Suspends Agents Operating On The Exchange Enrollment Platform The Centers for Medicare and Medicaid Services (CMS) has suspended 450 agents and brokers from selling products through healthcare.gov, which enrolls the uninsured in the Exchange program. The move was one in a number of reforms to stop illegal switching of enrollees and fraudulent enrollments. (Article may require a subscription.) #exchanges #aca #obamacare #marketing #fwa https://insidehealthpolicy.com/daily-news/cciio-suspends-450-agents-brokers-selling-through-healthcaregov Hospital Groups Wants Government To Take Action on J & J’s 340B Policy Change Hospital groups want the federal government to take action against Johnson & Johnson for requiring hospitals and other eligible providers to pay full price up front for two medications before the drug maker then pays a rebate or discount later. The federal government has warned J & J it must accept payment of the discounted amount from eligible providers. (Article may require a subscription.) #340b #hospitals #providers #drugpricing #branddrugmakers https://www.modernhealthcare.com/legal/johnson-johnson-340b-drug-pricing-aha-aeh-hrsa Hospital

Read More »
Logo

August 28, 2024

Fallout From Part D Legislation Remains The fallout from the major reductions in out-of-pocket (OOP) costs and transfer of liability to Part D plans in the Inflation Reduction Act (IRA) continues. The Centers for Medicare and Medicaid Services (CMS) saw massive increases in standalone Part D plans when bids for 2025 were submitted by insurers and the agency quickly created what I think is an extra-legal special subsidy program to limit premium increases in the program. The changes also impact Medicare Advantage (MA) and will contribute to cuts and premium increases there as well for 2025. The GOP in Congress has asked the congressional Government Accountability Office (GAO) to investigate and now is asking the Congressional Budget Office (CBO) what costs will be. I will have a special blog on this next week. My previous blogs on this are here:  https://www.healthcarelabyrinth.com/will-democrats-be-victim-of-an-october-surprise-of-their-own-making/ and https://www.healthcarelabyrinth.com/part-d-premium-woes-due-to-the-inflation-reduction-act/ . I have argued that while the

Read More »
Logo

August 27, 2024

Oregon Hospital Price Ceilings Reduce Plan And Patient Costs But Could Increase Utilization A good article discussing Oregon’s law capping maximum in-network hospital payments to 200% of Medicare and out-of-network prices at 185% at 24 urban hospitals. These are modest reforms, but good ones. They tie to my recent blog on center-left think tank Third Way finding commercial prices can come down and hospitals can make a profit (blog here: https://www.healthcarelabyrinth.com/the-truth-about-hospital-costs-and-payments/ ). One study of the Oregon experience thus far found health plan savings of $108 million in the first 27 months. A second study finds reduced out-of-pocket costs for patients of 9.5% or about $800,000 annually in the first 27 months. The law began in October 2019. There is some evidence that the lower hospital costs drove some utilization. A 4.8% uptick in outpatient procedures per enrollee per year was registered.  But in my view, this could be good

Read More »
Logo

August 26, 2024

Biden Administration Announces Exchange Navigator Grants The Centers for Medicare and Medicaid Services (CMS) announced navigator grants totaling $100 million to forty-four organizations to aid in enrollment in the Exchanges. The agency will distribute up to $500 million over the next five years. The organizations are in twenty-eight states with federally facilitated marketplaces. CMS Press Release: https://www.cms.gov/newsroom/press-releases/biden-harris-administration-awards-100-million-navigators-who-will-help-millions-americans (Some articles may require a subscription.) #aca #exchanges #obamacare #marketing https://www.modernhealthcare.com/policy/insurance-navigators-grants-cms-open-enrollment-2024 McKesson To Acquire Majority In FL Oncology Group McKesson signed a definitive agreement to acquire a 70% controlling stake in Community Oncology Revitalization Enterprise Ventures LLC, or Core Ventures, for $2.5 billion in cash. The group owns Florida Cancer Specialists & Research Institute, a major specialty provider group. McKesson’s oncology platform will be integrated into the FL group’s care. This is a good example of vertical integration as McKesson is a major force in the drug supply chain. Additional article: https://www.modernhealthcare.com/mergers-acquisitions/mckesson-corp-core-ventures-controlling-stake (Some

Read More »
Logo

August 23, 2024

Healthcare Services Company Evolent Health Could be Sold; United Healthcare Could Acquire Surgery Group Evolent Health, a company that offers software and clinical solutions to providers and health plans, could be acquired by either a private equity firm or Elevance Health. In other news, Surgery Partners, a major surgery center, urgent care, and provider group, could be sold to United Healthcare. Additional article: https://www.modernhealthcare.com/mergers-acquisitions/tpg-unitedhealth-group-surgery-partners (Some articles may require a subscription.) #manda #acquisitions #consolidations #healthcare #unitedhealthcare https://www.fiercehealthcare.com/payers/evolent-health-considers-sale-pe-stock-price-leaps Harris Promises To Defend Affordable Care Act and Medicare In her Democratic presidential acceptance speech, Vice President Kamala Harris promised to defend the Affordable Care Act and Medicare. (Article may require a subscription.) #election2024 #harris #medicare #aca #obamacare #exchanges https://insidehealthpolicy.com/daily-news/harris-promises-defend-aca-medicare-nomination-speech Clover Health Not Impacted By Medicare Advantage Headwinds Clover Health says it has avoided the headwinds impacting many other Medicare Advantage (MA) plans. Clover Health has over 80,000 members, almost all of them in Preferred

Read More »

Available Now

$30.00